Table 4.
Variables | Disease-free survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | p-value | aHRa | 95% CI | p-value | |
Age at surgery, years | 1.05 | 1.02–1.07 | 0.001 | 1.03 | 1.00–1.07 | 0.04 |
Female sex | 0.87 | 0.54–1.38 | 0.55 | 0.48 | 0.23–0.98 | 0.04 |
BMI, kg/m2 | 0.96 | 0.91–1.00 | 0.06 | |||
Tumor site | ||||||
Colon (reference) | ||||||
Rectum | 0.61 | 0.36–1.04 | 0.07 | |||
CRC stage | ||||||
In situ, I, II (reference) | ||||||
III, IV | 3.23 | 2.08–5.01 | < 0.001 | 3.15 | 1.85–5.36 | < 0.001 |
Charlson comorbidity index | 1.21 | 1.08–1.36 | 0.001 | |||
Complications of diabetes | 2.31 | 1.39–3.84 | 0.001 | |||
Metformin use | 0.36 | 0.23–0.56 | < 0.001 | 0.31 | 0.18–0.54 | < 0.001 |
HR, hazard ratio; CI, confidence interval.
aAdjusted for age at surgery, sex, BMI, tumor site, CRC stage, Charlson comorbidity index, diabetes complications.